Syngene International Ltd.(IN:SYNGENE)
₹447.65+4.85 (+1.10%)
IN:SYNGENE
Syngene International Ltd. Revenue
₹447.65
At close:+4.85 (+1.10%)
Want to see IN:SYNGENE full AI Analyst Report?
Syngene International Ltd. (SYNGENE) Revenue
7 Followers
Syngene International Ltd. Revenue
Syngene International Ltd. had a revenue of 8.33B in the quarter ending Sep 30, 2026, with 13.14%. This bring the company's revenue in the last twelve months to 35.22B, Decreased 2.16%. In the fiscal year ending Mar 31, 2026, Syngene International Ltd. had annual revenue of 37.39B with 2.64% growth.
- Revenue (ttm)
- 35.22B
- Revenue Growth
- -5.99%
- P/S Ratio
- 4.78
- Revenue/Employee
- INR 5,586,820
- Employees
- 6,692
- Market Cap
- INR 178.74B
Revenue Chart
Syngene International Ltd. Revenue - Annual
Revenue History
| Fiscal End Date | Revenue | Change | Growth |
|---|---|---|---|
| Mar 31, 2026 | 37.39B | 963.00M | 2.64% |
| Mar 31, 2025 | 36.42B | 1.54B | 4.41% |
| Mar 31, 2024 | 34.89B | 2.96B | 9.26% |
| Mar 31, 2023 | 31.93B | 5.89B | 22.61% |
| Mar 31, 2022 | 26.04B | 4.20B | 19.22% |
| Mar 31, 2021 | 21.84B | 1.72B | 8.57% |
| Mar 31, 2020 | 20.12B | 1.86B | 10.20% |
| Mar 31, 2019 | 18.26B | 4.03B | 28.28% |
| Mar 31, 2018 | 14.23B | 2.22B | 18.50% |
| Mar 31, 2017 | 12.01B | ― | ― |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Related Stocks
| Company | Revenue |
|---|---|
| IN:SYNGENE | 35.22B |
| IN:BIOCON | 174.15B |
| IN:CONCORDBIO | 11.70B |
| IN:DCAL | 22.92B |
| IN:PANACEABIO | 6.73B |
| IN:ANTHEM | 10.33B |